320 related articles for article (PubMed ID: 9694726)
1. Characterization of a novel human natural killer-cell line (NK-YS) established from natural killer cell lymphoma/leukemia associated with Epstein-Barr virus infection.
Tsuchiyama J; Yoshino T; Mori M; Kondoh E; Oka T; Akagi T; Hiraki A; Nakayama H; Shibuya A; Ma Y; Kawabata T; Okada S; Harada M
Blood; 1998 Aug; 92(4):1374-83. PubMed ID: 9694726
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus (EBV)-induced CD30+ natural killer cell-type malignancy resembling malignant histiocytosis: malignant transformation in chronic active EBV infection associating hypogammaglobulinemia.
Tsutsumi Y; Tang X; Yamada T
Pathol Int; 1997 Jun; 47(6):384-92. PubMed ID: 9211526
[TBL] [Abstract][Full Text] [Related]
3. EBV-NK cells interactions and lymphoproliferative disorders.
Kanegane H; Yachie A; Miyawaki T; Tosato G
Leuk Lymphoma; 1998 May; 29(5-6):491-8. PubMed ID: 9643562
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus is localized in the tumour cells of nasal lymphomas of NK, T or B cell type.
Tao Q; Ho FC; Loke SL; Srivastava G
Int J Cancer; 1995 Jan; 60(3):315-20. PubMed ID: 7829236
[TBL] [Abstract][Full Text] [Related]
5. A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation.
Yagita M; Huang CL; Umehara H; Matsuo Y; Tabata R; Miyake M; Konaka Y; Takatsuki K
Leukemia; 2000 May; 14(5):922-30. PubMed ID: 10803526
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr viral DNA in acute large granular lymphocyte (natural killer) leukemic cells.
Hart DN; Baker BW; Inglis MJ; Nimmo JC; Starling GC; Deacon E; Rowe M; Beard ME
Blood; 1992 Apr; 79(8):2116-23. PubMed ID: 1314113
[TBL] [Abstract][Full Text] [Related]
7. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.
Chan JK; Sin VC; Wong KF; Ng CS; Tsang WY; Chan CH; Cheung MM; Lau WH
Blood; 1997 Jun; 89(12):4501-13. PubMed ID: 9192774
[TBL] [Abstract][Full Text] [Related]
8. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus.
Kanavaros P; Lescs MC; Brière J; Divine M; Galateau F; Joab I; Bosq J; Farcet JP; Reyes F; Gaulard P
Blood; 1993 May; 81(10):2688-95. PubMed ID: 8387835
[TBL] [Abstract][Full Text] [Related]
9. Lymphoproliferative disorders of natural killer cells.
Oshimi K
Int J Hematol; 1996 Jun; 63(4):279-90. PubMed ID: 8762811
[TBL] [Abstract][Full Text] [Related]
10. Inconsistent association of Epstein-Barr virus with CD56 (NCAM)-positive angiocentric lymphoma occuring in sites other than the upper and lower respiratory tract.
Kobashi Y; Nakamura S; Sasajima Y; Koshikawa T; Yatabe Y; Kitoh K; Mori S; Ueda R; Yamabe H; Suchi T
Histopathology; 1996 Feb; 28(2):111-20. PubMed ID: 8834518
[TBL] [Abstract][Full Text] [Related]
11. The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.
Xu ZG; Iwatsuki K; Oyama N; Ohtsuka M; Satoh M; Kikuchi S; Akiba H; Kaneko F
Br J Cancer; 2001 Apr; 84(7):920-5. PubMed ID: 11286472
[TBL] [Abstract][Full Text] [Related]
12. Nasal NK/T cell lymphoma in Taiwan: a clinicopathologic study of 22 cases, with analysis of histologic subtypes, Epstein-Barr virus LMP-1 gene association, and treatment modalities.
Kuo TT; Shih LY; Tsang NM
Int J Surg Pathol; 2004 Oct; 12(4):375-87. PubMed ID: 15494863
[TBL] [Abstract][Full Text] [Related]
13. Nasal natural killer/T-cell lymphoma and its association with type "i"/XhoI loss strain Epstein-Barr virus in Chile.
Cabrera ME; Eizuru Y; Itoh T; Koriyama C; Tashiro Y; Ding S; Rey S; Akiba S; Corvalan A
J Clin Pathol; 2007 Jun; 60(6):656-60. PubMed ID: 16775124
[TBL] [Abstract][Full Text] [Related]
14. Nasal T/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage.
Chiang AK; Chan AC; Srivastava G; Ho FC
Int J Cancer; 1997 Nov; 73(3):332-8. PubMed ID: 9359478
[TBL] [Abstract][Full Text] [Related]
15. Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement.
Kato N; Yasukawa K; Onozuka T; Kikuta H
J Am Acad Dermatol; 1999 May; 40(5 Pt 2):850-6. PubMed ID: 10321634
[TBL] [Abstract][Full Text] [Related]
16. P53, N- and K-Ras, and beta-catenin gene mutations and prognostic factors in nasal NK/T-cell lymphoma from Hokkaido, Japan.
Takahara M; Kishibe K; Bandoh N; Nonaka S; Harabuchi Y
Hum Pathol; 2004 Jan; 35(1):86-95. PubMed ID: 14745729
[TBL] [Abstract][Full Text] [Related]
17. Presence of natural killer-cell clones with variable proliferative capacity in chronic active Epstein-Barr virus infection.
Nagata H; Numata T; Konno A; Mikata I; Kurasawa K; Hara S; Nishimura M; Yamamoto K; Shimizu N
Pathol Int; 2001 Oct; 51(10):778-85. PubMed ID: 11881730
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8.
Horenstein MG; Nador RG; Chadburn A; Hyjek EM; Inghirami G; Knowles DM; Cesarman E
Blood; 1997 Aug; 90(3):1186-91. PubMed ID: 9242551
[TBL] [Abstract][Full Text] [Related]
19. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease.
Chiang AK; Tao Q; Srivastava G; Ho FC
Int J Cancer; 1996 Nov; 68(3):285-90. PubMed ID: 8903467
[TBL] [Abstract][Full Text] [Related]
20. Monomorphic agranular natural killer cell lymphoma/leukemia with no Epstein-Barr virus association.
Matano S; Nakamura S; Nakamura S; Annen Y; Hattori N; Kobayashi K; Kyoda K; Sugimoto T
Acta Haematol; 1999; 101(4):206-8. PubMed ID: 10436303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]